title: Liver transplantation for inherited metabolic disorders of the liver.
abstract: OBJECTIVE
  Liver transplantation is curative, life saving or both for a range of inherited diseases affecting the liver. Indications, timing and outcome of transplantation for these diseases are the focus of this review.
  
  
  RESULTS
  Liver transplant represents a mode of gene replacement therapy for several disorders, including Wilson disease, hemochromatosis, tyrosinemia, urea cycle defects and hypercholesterolemia in which the primary defect residing in the liver results in hepatic complications or severe extrahepatic disease. Liver transplant is also an important therapeutic modality in multisystemic genetic disorders with major hepatic disease such as glycogen storage disease types I, III and IV and porphyria. For familial amyloidosis and primary hyperoxaluria, liver replacement eliminates the source of the injurious products that results in extrahepatic disease. Innovations in medical and surgical management of these patients have led to improved outcomes providing an important benchmark for future gene therapy of these disorders.
  
  
  CONCLUSIONS
  Recent developments have refined the indications for liver transplant in the treatment of inherited metabolic diseases. The full potential of liver transplant in these disorders can be harnessed by careful patient selection, optimizing timing and perioperative metabolic management of these patients.
authors.affiliation: Shiraz University of Medical Science, Shiraz, Iran.
authors.forename: Maryam
authors.initials: M
authors.lastname: Moini
authors.forename: Pramod
authors.initials: P
authors.lastname: Mistry
authors.forename: Michael L
authors.initials: ML
authors.lastname: Schilsky
mesh_terms: D028226:Amyloidosis, Familial / Q000601:surgery; D006008:Glycogen Storage Disease / Q000601:surgery; D006432:Hemochromatosis / Q000601:surgery; D006527:Hepatolenticular Degeneration / Q000601:surgery; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000601:surgery; D006960:Hyperoxaluria, Primary / Q000601:surgery; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation; D008661:Metabolism, Inborn Errors / Q000601:surgery*; D018579:Patient Selection; D011164:Porphyrias / Q000601:surgery; D013997:Time Factors; D016896:Treatment Outcome